Grace Therapeutics Announces Third Fiscal Quarter 2025Financial Results, Provides Business Update
Announced Phase 3 STRIVE-ON Safety Trial Met Primary Endpoint and Provided Clinical…
Annovis Bio, Inc. Announces Closing of $21 Million Public Offering
MALVERN, PA, Feb. 04, 2025 (GLOBE NEWSWIRE) -- via IBN - Annovis Bio,…
BriaCell Therapeutics Announces Pricing of Public Offering
February 03, 2025 19:59 ET | Source: BriaCell Therapeutics Corp. PHILADELPHIA and…
Reliance Infrastructure Proceeds to Complete the Acquisition of Pipavav Defence and Offshore Engineering Company Limited
Reliance Infrastructure Limited today announced that all requisite approvals including the approval…
Beta Bionics Announces Closing of $234.6 Million Initial Public Offering and Full Exercise of Underwriters Option to Purchase Additional Shares
January 31, 2025 17:56 ET | Source: Beta Bionics, Inc. IRVINE, Calif.,…
Zhengye Biotechnology Holding Limited Announces Closing of Initial Public Offering
Jilin, China, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited…
Microbot Medical Raises a Total of Approximately $11.8 Million in Gross Proceeds from Registered Direct Offering and Previously Announced ATM Facility
January 07, 2025 16:15 ET | Source: Microbot Medical Inc. HINGHAM, Mass.,…
Zhengye Biotechnology Holding Limited Announces Pricing of Initial Public Offering
Jilin, China, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited…
NETCLASS TECHNOLOGY INC Announces Full Exercise of Over-Allotment Option
January 03, 2025 16:05 ET | Source: NETCLASS TECHNOLOGY INC. SHANGHAI and…
HUTCHMED Announces US$608 million Divestment of Non-Core JointVenture
— HUTCHMED continues to deliver on its strategy outlined in November 2022 to…